[Sudden infant death syndrome]

Akilo Sawaguchi1, Toshiko Sawaguchi

  • 1Tokyo University of Social Welfare, Tokyo Women's Medical University.

Insights

Sudden infant death syndrome (SIDS) is unexplained infant mortality. This study reviews SIDS epidemiology, pathogenesis, and prevention strategies, addressing associated social challenges.

Area of Science:

  • Pediatrics
  • Pathology
  • Public Health

Context:

  • Sudden Infant Death Syndrome (SIDS) remains a significant cause of infant mortality with profound family impact.
  • Unexplained infant deaths necessitate a clear definition and diagnostic approach, including autopsy.
  • Potential legal ramifications arise from SIDS cases in care facilities, involving professional responsibility.

Purpose:

  • To comprehensively review the epidemiology, pathogenesis, and physiopathology of Sudden Infant Death Syndrome (SIDS).
  • To explore current prospects for SIDS prevention.
  • To discuss the social problems and implications associated with SIDS.

Summary:

  • Defines SIDS as sudden, unexplained infant death, requiring autopsy for diagnosis.
  • Examines SIDS's epidemiological patterns, underlying biological mechanisms, and physiological disruptions.
  • Discusses preventative measures and the societal impact on families and institutions.

Impact:

  • Provides a foundational understanding of SIDS for researchers and healthcare professionals.
  • Highlights the importance of ongoing research into SIDS etiology and prevention.
  • Informs public health strategies and support systems for families affected by SIDS.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...